Home » Stocks » Axonics Modulation Technologies

Axonics Modulation Technologies, Inc. (AXNX)

Stock Price: $40.86 USD 0.44 (1.09%)
Updated Jul 9, 2020 2:51 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 1.41B
Revenue (ttm) 39.04M
Net Income (ttm) -81.43M
Shares Out 39.12M
EPS (ttm) -2.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 9, 2020
Last Price $40.86
Previous Close $40.42
Change ($) 0.44
Change (%) 1.09%
Day's Open 40.39
Day's Range 39.32 - 40.95
Day's Volume 670,076
52-Week Range 15.25 - 41.37

More Stats

Market Cap 1.41B
Enterprise Value 1.28B
Earnings Date (est) Aug 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 39.12M
Float 24.66M
EPS (basic) -2.75
EPS (diluted) -2.71
FCF / Share -2.84
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.98M
Short Ratio 7.26
Short % of Float 12.94%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 36.13
PB Ratio 8.59
Revenue 39.04M
Operating Income -81.69M
Net Income -81.43M
Free Cash Flow -95.41M
Net Cash 128.97M
Net Cash / Share 3.74
Gross Margin 18.78%
Operating Margin -209.24%
Profit Margin -208.60%
FCF Margin -244.39%
ROA -27.10%
ROE -53.61%
ROIC -119.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (8)

Buy 8
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$45.38*
(11.06% upside)
Low
42.0
Current: 40.86
High
50.0
Target: 45.38
*Average 12-month price target from 8 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016
Revenue13.820.710.13-
Revenue Growth1854.74%452.34%--
Gross Profit7.330.350.01-
Operating Income-80.60-32.14-18.17-17.48
Net Income-79.94-32.48-18.06-17.40
Shares Outstanding28.577.002.562.31
Earnings Per Share-2.80-4.64-7.04-7.52
Operating Cash Flow-83.45-31.37-18.18-17.34
Capital Expenditures-1.34-1.23-1.04-0.29
Free Cash Flow-84.79-32.60-19.21-17.63
Cash & Equivalents18415824.408.21
Total Debt25.3923.510.140.30
Net Cash / Debt15813424.267.91
Assets22017229.4110.86
Liabilities36.8228.632.541.79
Book Value183143-97.49-62.58
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Axonics Modulation Technologies, Inc.
Country United States
Employees 302
CEO Raymond Wayne Cohen

Stock Information

Ticker Symbol AXNX
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: AXNX

Description

Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems in the United States and internationally. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence, and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is based in Irvine, California.